News

Stargate, a $500B U.S. datacenter project spearheaded by SoftBank Group (OTCPK:SFTBY) (OTCPK:SFTBF) and OpenAI, is mulling a ...
In its first quarter 2025 investor letter, ClearBridge Value Strategy emphasized stocks such as Oracle Corporation (NYSE:ORCL). Oracle Corporation (NYSE:ORCL) offers products and services that address ...
While some of the featured leaders were ones you’d expect—cabinet nominees, congressional leaders, megadonor Elon Musk—at least one was a surprise: Masayoshi Son, the Japanese billionaire ...
NYSE ORCL opened at $128.17 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The company has a fifty day simple moving average of $160. ...
In its fourth quarter 2024 investor letter, Artisan Global Opportunities Fund emphasized stocks such as Oracle Corporation (NYSE:ORCL). Oracle Corporation (NYSE:ORCL) offers products and services ...
The Tokyo-based company, led by billionaire Masayoshi Son, said it expected its first $10 billion chunk of the deal would be financed by borrowing from Japanese bank Mizuho and other lenders and ...
SoftBank which is leading the deal will initially be investing $7.5 billion in the company along with $2.5 billion from an investor syndicate. OpenAI has finalised a $40 billion funding round from ...
Sam Altman’s OpenAI has raised $40 billion in a new funding round led by investment giant SoftBank as it looks to stave off rivals like Elon Musk’s xAI and China-based DeepSeek. The ChatGPT ...
While some of the featured leaders were ones you’d expect—cabinet nominees, congressional leaders, megadonor Elon Musk—at least one was a surprise: Masayoshi Son, the Japanese billionaire tech ...
According to a Bloomberg report, hackers have broken into Oracle’s (ORCL) systems and stolen sensitive patient data, targeting multiple U.S. healthcare providers in what looks like a widespread ...
My son is 8 and doctors are saving his life but worries we can go extinct from stupidity. He’s not wrong. News Editor Allison Quinn is writing a series of columns about her son’s treatment for ...